News
ReNeuron's latest press releases
Office of Life Sciences. 27/01/10
Guildford, UK, 27 January 2010: ReNeuron Group plc (LSE: RENE.L) welcomes yesterday’s launch of the “Life Sciences 2010: Delivering the …
Read articleRegulatory Update. 11/01/10
Guildford, UK, 11 January 2010: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke …
ReNeuron awarded two grants under regenerative medicine funding programme established by UK Government . 27/11/09
Guildford, UK, 27 November 2009: ReNeuron Group plc (LSE: RENE.L) announces that it has been awarded two grants under the Government-backed …
Interim Results for the six months ended 30 September 2009 . 26/11/09
ReNeuron announces its interim results for the period ending 30th September 2009. Full details can be downloaded from the Company's website at www.…
ReNeuron secures £5 million equity funding facility . 26/11/09
Guildford, UK, 26 November 2009: ReNeuron Group plc (LSE: RENE.L; “the Company”) announces that it has secured a two-year equity funding …
Notification of Interim Results. 23/11/09
Guildford, UK, 23 November 2009: ReNeuron Group plc (LSE: RENE.L) today announces that it will report its interim results for the six months ending 30 …
ReNeuron presents positive pre-clinical efficacy data with ReN009 stem cell therapy for peripheral arterial disease at leading US scientific conference. 16/11/09
Guildford, UK, 16 November 2009: ReNeuron Group plc (LSE: RENE.L) announces further positive pre-clinical efficacy data with its ReN009 stem cell …
Click below to view BioBusiness.TV's Stem Cell Review series, featuring Dr John Sinden, ReNeuron's Chief Scientific Officer. 26/10/09
Episode 1: Stem Cells at a Glance http://biobusiness.tv/videos/201 Episode 2: Allogeneic or Autologous? http://biobusiness.tv/videos/202 Episode 3:…
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page